OCBCO
ABBV icon

Oversea-Chinese Banking Corp (OCBC)’s AbbVie ABBV Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.14M Buy
14,437
+13,367
+1,249% +$2.97M 0.08% 157
2025
Q4 		$244K Sell
1,070
-1,892
-64% -$431K 0.01% 308
2025
Q3 		$686K Buy
2,962
+1,070
+57% +$218K 0.02% 235
2025
Q2 		$351K Sell
1,892
-3,795
-67% -$705K 0.01% 279
2025
Q1 		$1.19M Buy
5,687
+1,978
+53% +$385K 0.03% 217
2024
Q4 		$659K Sell
3,709
-5,208
-58% -$958K 0.02% 260
2024
Q3 		$1.75M Buy
8,917
+4,217
+90% +$787K 0.05% 188
2024
Q2 		$806K Buy
4,700
+1,920
+69% +$318K 0.02% 244
2024
Q1 		$506K Sell
2,780
-6,827
-71% -$1.18M 0.02% 287
2023
Q4 		$1.49M Buy
9,607
+1,045
+12% +$152K 0.05% 158
2023
Q3 		$1.28M Buy
8,562
+6,427
+301% +$943K 0.06% 176
2023
Q2 		$288K Sell
2,135
-9,215
-81% -$1.35M 0.01% 279
2023
Q1 		$1.81M Buy
11,350
+7,574
+201% +$1.16M 0.09% 142
2022
Q4 		$610K Buy
+3,776
New +$579K 0.04% 203

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s ABBV Position: Q1 2026 in Review

Oversea-Chinese Banking Corp (OCBC) increased its AbbVie (ABBV) stake by 1,249% in Q1 2026, buying an estimated $2.97M and bringing the position to 14,437 shares worth $3.14M. The position accounts for 0.08% of the portfolio, ranked #157.

Oversea-Chinese Banking Corp (OCBC) first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 14,437 shares of AbbVie worth $3.14M as of Q1 2026.
  • Oversea-Chinese Banking Corp (OCBC) bought 13,367 AbbVie shares in Q1 2026, an estimated $2.97M.
  • AbbVie made up 0.08% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q1 2026, its #157 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2026, filed 28 Apr 2026.